TORONTO, July 27, 2026 /CNW/ -- DeFi Technologies Inc. (the "Company" or "DeFi Technologies") (NASDAQ:DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance ("DeFi"), today issued a Letter to Shareholders from its Chief Executive Officer and Executive Chairman, Johan Wattenström. Dear Shareholders,First, I want to take the opportunity to assure all shareholders that management and the team take the share price decline very seriously. We are all shareholders ourselves, and we feel the impact alongside you.Our share price has always been highl
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- DeFi Technologies Issues CEO Letter to Shareholders
- QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP
Ness Ziona, Israel, July 27, 2026 (GLOBE NEWSWIRE) -- QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP Ness Ziona, Israel, July 27, 2026 – QTREX Quantum Ltd. (NASDAQ:QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure today announced the launch of a research collaboration with Northeastern University in Massachusetts, focused on advanced micro-system structures for cryogenic quantum interconnects. Pursuant to the collaboration agreement, Northeastern University has agreed to provide QTREX with a first option to negotiate a commercial licens
- Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery
Collaboration with NVIDIA and Google Cloud Provide Additional Tools and Compute Access Schrödinger, Inc. (NASDAQ:SDGR) today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist that helps researchers understand scientific objectives, develop computational strategies, execute sophisticated molecular discovery workflows and interpret results. By combining AI with physics-based simulation, Bunsen allows researchers to apply their expertise at greater scale, enabling them to explore more scientific possibilities, prioritize the most promising opportunities with greater confidence and accelerate discovery decisions. Advances in computer-aided drug disc
- Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut
WEST PALM BEACH, Florida, July 27, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (NASDAQ:QUCY) ("Quantum Cyber" or the "Company"), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that its wholly owned subsidiary, Quantum Drones Corporation, has completed the manufacturing and assembly of its first mini-interceptor drone at the Company’s newly acquired U.S.-based manufacturing facility in Bridgeport, Connecticut. The milestone marks the first in-house drone produced by Quantum Cyber following the closing on July 15, 2026, of the approximately 50,000 squa
- OPAL Fuels Announces Second Quarter 2026 Earnings Release Date and Conference Call
OPAL Fuels (NASDAQ:OPAL) a leader in the production, marketing, and distribution of renewable and compressed natural gas (RNG and CNG) used as a transportation fuel for heavy duty trucking, today announced that it will release its earnings results for the second quarter ended June 30, 2026, before market open on Monday, August 10, 2026. A conference call will take place on Monday, August 10, 2026 at 11:00 a.m. Eastern Time.A listen-only connection to the investor presentation will be accessible at https://edge.media-server.com/mmc/p/qp5g7dch. Investors can also listen to a webcast of the presentation on the company's Investor Relations website at https://investors.opalfuels.com/news-events/e
- Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer
MILLBRAE, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (NASDAQ:EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced that the first patient has been dosed in TeLuRide-008, a Phase 2/3 registrational study evaluating EIK1001 in combination with pembrolizumab and histology-appropriate chemotherapy as first-line therapy for treatment-naïve patients with stage 4 Non-Small Cell Lung Cancer (NSCLC). "Treating the first patient in TeLuRide-008 is a significant milestone for Eikon as we continue to advance EIK1001 in multiple indications, with the ultimate goal of de
- Indonesia Energy Corporation Commences Drilling of K-29 Well
The First of Two New Planned Wells at Kruh Block in 2026 JAKARTA, INDONESIA AND DANVILLE, CA, July 27, 2026 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE:INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that on Saturday, July 25, 2026, its "K-29" well was spudded and drilling commenced. The planned total depth of the well is 3,400 feet. The spudding of K-29 comes less than three weeks following IEC’s announcement of the formal commencement of well operations at the site in advance of actual drilling. The following video link captures the spudding of the well and the commencement of drilling: https://youtube.com/shorts/nK-8oC
- Frequency Electronics Inc. Announces Space Mission Contract Award Valued at Approximately $8 million
MITCHEL FIELD, N.Y., July 27, 2026 (GLOBE NEWSWIRE) -- Frequency Electronics, Inc. ("FEI" or the "Company") (NASDAQ-FEIM), a leading provider of precision timing and frequency control products for space and terrestrial applications, is pleased to announce the award of a follow-on production contract for approximately $8 million, for compact, highly precise atomic clocks to support position, navigation, and timing (PNT) for lunar space missions. FEI President and CEO, Tom McClelland, commented, "Once again FEI is proud to support its valued repeat customers, underscoring our commitment to delivering technically robust, mission-ready products for space applications. These repeat awards refl
- US Defense Manufacturer, Elmet Technologies, to Streamline Supply Chain for Rapid Production of Hypersonic Vehicle Parts with 3D Systems DMP Flex 350 Triple
Made advancements for C103 material with 3D Systems AIG GroupExpects fast qualification and certification of machines and materialsFocuses on a fast, streamlined domestic supply chain ROCK HILL, S.C., July 27, 2026 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced that Elmet Technologies, a wholly owned subsidiary of The Elmet Group (NASDAQ:ELMT) ("Elmet"), is deploying the DMP Flex 350 Triple metal additive manufacturing machine (laser powder bed fusion) for the rapid production of advanced aerospace parts for hypersonic vehicles. Utilizing a high-performance C103 material, the Elmet team expects to rapidly qualify and certify the system to begin production in 2026. High-perfor
- NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License
NEWPORT BEACH, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- NorthStrive Defense Tech LLC ("NorthStrive Defense Tech"), a wholly owned subsidiary of PMGC Holdings Inc. (the "Company") (NASDAQ:ELAB), today announced that it has entered into a project services agreement with Deploy360 to conduct independent validation and testing of the patented GPS-denied autonomous navigation technology currently under option by NorthStrive Defense Tech. The project is intended to provide NorthStrive Defense Tech with an independent technical assessment of the technology’s software, architecture, dependencies, and performance under controlled, simulation-based conditions. The technology is covered by U.S. Pa
- Arrowhead Pharmaceuticals Completes Enrollment in Global Phase 3 YOSEMITE Study of Zodasiran for the Treatment of Homozygous Familial Hypercholesterolemia
- Study completion anticipated in mid-2027 Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has completed enrollment in the global Phase 3 YOSEMITE clinical trial of zodasiran, the company’s investigational RNA interference (RNAi) therapeutic being developed as a potential treatment for homozygous familial hypercholesterolemia (HoFH), a rare genetic condition that leads to severely elevated low density lipoprotein-cholesterol (LDL-C) and early onset cardiovascular disease. Arrowhead anticipates that YOSEMITE will be completed in mid-2027 and, pending successful clinical results, intends to seek regulatory approval in multiple geographies thereafter. "Completing enro
- Ponce Financial Group, Inc. Reports Second Quarter 2026 Results
NEW YORK, July 27, 2026 (GLOBE NEWSWIRE) -- Ponce Financial Group, Inc., (the "Company") (NASDAQ:PDLB), the holding company for Ponce Bank, National Association ("Ponce Bank" or the "Bank"), today announced results for the second quarter of 2026. Second Quarter 2026 Highlights (Compared to Prior Periods): Net income available to common stockholders was $8.2 million, or $0.35 per diluted share for the three months ended June 30, 2026, as compared to net income available to common stockholders of $8.3 million, or $0.36 per diluted share for the three months ended March 31, 2026 and net income available to common stockholders of $5.8 million, or $0.25 per diluted share for the three months
- Honeywell Technologies Completes Sale of Warehouse and Workflow Solutions Business to American Industrial Partners
Honeywell Technologies (NASDAQ:HON) today announced it has completed the sale of its Warehouse and Workflow Solutions (WWS) business to American Industrial Partners (AIP) in an all-cash transaction. The business operates commercially under the Intelligrated and Transnorm brands. The divestiture of WWS allows Honeywell Technologies to further focus on its pure-play automation portfolio in the Building, Industrial and Process end markets, and the long-term growth opportunities aligned with the industrial sector’s transition from automation to autonomy. "The completion of the WWS divestiture further sharpens Honeywell Technologies as a pure-play automation company," said Vimal Kapur, chair
- TransDigm Announces Acquisition of Prince & Izant
CLEVELAND, July 27, 2026 /PRNewswire/ -- TransDigm Group Incorporated (NYSE:TDG) today announced it has entered into a definitive agreement to acquire Prince & Izant ("P&I" or "the Company"), a portfolio company of Industrial Growth Partners, for approximately $1.066 billion in cash, including certain tax benefits. Headquartered in Cleveland, Ohio, Prince & Izant is a leading global designer and manufacturer of highly engineered brazing alloys and specialty metal components used across a range of advanced performance and high cost-of-failure applications. The Company primarily supports the aerospace and defense, aeroderivative
- Sharon AI to Announce Second Quarter 2026 Results
NEW YORK, July 27, 2026 /PRNewswire/ -- Sharon AI Holdings Inc. (NASDAQ:SHAZ) and its subsidiaries ("Sharon AI"), a leading Australian Neocloud, will release its second quarter 2026 financial results after the market closes on Thursday, August 6, 2026, followed by a conference call and webcast to discuss the results. SHAZ)" alt="Sharon AI (NASDAQ:SHAZ)"> Conference Call and Webcast DetailsDate & Time: Thursday, August 6, 2026, 4:30 p.m. ETWebcast: Use this linkU.S. Dial-in: 888-506-0062International Dial-in: 973-528-0011Conference ID: 376509A replay of the webcast will be available at sharonai.com/investors following the event.A
- Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns
Names Veteran Health Tech & AI Services Leader Sumit Ganguli as Chairman & CEO to Fuel Multi-Year Recurring Revenue Growth Across a Multi-Billion-Dollar Healthcare AI MarketPLEASANTON, Calif., July 27, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary. Ganguli brings an established track record of building elite technology and he
- Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meeting of Shareholders
ISS has recommended that Aurora's shareholders vote FOR all director nominees and meeting resolutionsShareholders are encouraged to vote early in favour of all resolutions – every vote matters, no matter how many shares you ownShareholders who have questions or need assistance with voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Kingsdale Advisors, by telephone at 1-800-749-9052 or by email at contactus@kingsdaleadvisors.com or visit www.MyAuroraVote.comEDMONTON, AB, July 27, 2026 /CNW/ -- Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) ("Aurora" or the "Company"), the Canadian-based leading global medical cannabis company, is pleased to announce that
- Domino's® Serves Up Summer Savings: All Menu-Priced Pizzas Are 50% Off July 27-Aug. 2
Customers can enjoy half off any size pizza, with any crust type and toppingsANN ARBOR, Mich., July 27, 2026 /PRNewswire/ -- Summer just got a whole lot tastier. Domino's Pizza Inc. (NASDAQ:DPZ) is helping customers make the most of the season by offering 50% off all menu-priced pizzas from July 27-Aug. 2. The deal is available for delivery or carryout and can be redeemed on dominos.com, via Domino's mobile app, over the phone or in person."Summer is all about making memories, whether that's a backyard get-together, family movie night or simply sharing a meal with friends," said Frank Garrido, Domino's executive vice president
- Costamare Inc. Reports Results for the Second Quarter and Six-Month Period Ended June 30, 2026
MONACO, July 27, 2026 (GLOBE NEWSWIRE) -- Costamare Inc. ("Costamare" or the "Company") (NYSE:CMRE) today reported unaudited financial results for the second quarter and six-month period ended June 30, 2026. PROFITABILITY AND LIQUIDITY Q2 2026 Adjusted Net Income from Continuing operations1 available to common stockholders2 of $75.1 million ($0.62 per share).Q2 2026 Net Income from Continuing operations1 available to common stockholders of $77.4 million ($0.64 per share).Q2 2026 liquidity of $423.0 million3. II. NEW BILATERAL FINANCING AGREEMENTS OF $1.3 BILLION WITH A NUMBER OF LEADING US, EUROPEAN AND ASIAN BANKS4 Concluded new financing agreements for $920 million and refina
- HBT Financial, Inc. Announces Second Quarter 2026 Financial Results
Second Quarter Highlights Net income of $27.8 million, or $0.76 per diluted share; return on average assets ("ROAA") of 1.66%; return on average stockholders' equity ("ROAE") of 14.73%; and return on average tangible common equity ("ROATCE")(1) of 17.69%Adjusted net income(1) of $28.5 million, or $0.78 per diluted share; adjusted ROAA(1) of 1.70%; adjusted ROAE(1) of 15.09%; and adjusted ROATCE(1) of 18.13%Asset quality remained strong with nonperforming assets to total assets of 0.15% and net recoveries to average loans of 0.01%, on an annualized basisNet interest margin increased 12 basis points to 4.32% and net interest margin (tax-equivalent basis)(1) increased 13 basis points to 4.38%